Beverly Hills 12/10/2009 1:01:06 AM
News / Business

Hi-Tech’s 2Q Profit Leaps As Generic Drug Sales Grow

Finance World News Update by EQUITIES Magazine

Today Hi-Tech Pharmacal Co. announced that its fiscal second-quarter profit surged due to formidable sales of generic drugs.

 

For the quarter ended Oct 31, Hi-Tech added that its profit rose to $7.4 million, or 60 cents per share, compared to a profit of $1.1 million, or 9 cents per share, one year ago. Revenue rose 63 percent to $40.9 million from $25.1 million.

 

Shares of Hi-Tech rose $2.22, or 10 percent, to $24.05 in morning trading.

 

About EQUITIES:

 

Since 1951, EQUITIES Magazine has been a leading media company providing business editorial content designed to serve the needs of business leaders, professionals, institutional investors and retail investors. We are focused on business and the business of making money, not on lifestyle subjects. We publish original reporting in print and on our website, as well as select content at www.nasdaq.com. For 28 years we have hosted our own branded investor conferences that connect public company CEO’s with our loyal readers in the investment community.

 

Sign up for a free one-year subscription to EQUITIES Magazine